Free Trial
NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$1.31 +0.03 (+2.34%)
As of 03:11 PM Eastern

About Gelteq Stock (NASDAQ:GELS)

Key Stats

Today's Range
$1.26
$1.33
50-Day Range
$1.26
$1.95
52-Week Range
$0.77
$5.50
Volume
12,088 shs
Average Volume
1.19 million shs
Market Capitalization
$12.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GELS Stock News Headlines

Head-To-Head Analysis: Gelteq (NASDAQ:GELS) & Legend Biotech (NASDAQ:LEGN)
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Gelteq Aktie | GELS Kurs | Realtime - Investing.com
Gelteq Ltd.
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $2.32 at the start of the year. Since then, GELS shares have decreased by 43.5% and is now trading at $1.31.

Gelteq (GELS) raised $5 million in an IPO on Tuesday, October 29th 2024. The company issued 1,300,000 shares at $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Gelteq's top institutional shareholders include Wedbush Securities Inc. (0.21%).

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/27/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
CIK
1920092
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.79
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$100 thousand
Price / Sales
123.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
1.01

Miscellaneous

Outstanding Shares
9,440,000
Free Float
N/A
Market Cap
$12.37 million
Optionable
N/A
Beta
N/A

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners